---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-059950"
form_type: "8-K"
ticker: "IPSC"
cik: "0001850119"
company_name: "Century Therapeutics, Inc."
filed_at: "2025-06-16T23:59:59+00:00"
generated_at: "2026-05-19T06:54:50.040108+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Century Therapeutics stockholders elect two Class I directors and ratify E&Y as auditor at annual meeting

## Summary
- Daphne Quimi elected with 52,593,454 votes for; Carlo Rizzuto elected with 51,373,990 votes for.
- Ratification of Ernst & Young LLP as independent auditor for 2025 passed with 71,768,193 votes for.
- Broker non-votes of 15,072,004 on director elections; no broker non-votes on auditor ratification.
- Annual meeting held virtually on June 12, 2025; record date April 16, 2025 with 86,158,758 shares outstanding.

## SEC filing metadata
- accession: 0001104659-25-059950
- form_type: 8-K
- ticker: IPSC
- cik: 0001850119
- company_name: Century Therapeutics, Inc.
- filed_at: 2025-06-16T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1850119/000110465925059950/0001104659-25-059950-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1850119/000110465925059950/tm2518111d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-059950
- JSON: https://secwatch.observer/filing/0001104659-25-059950.json
- Plain text: https://secwatch.observer/filing/0001104659-25-059950.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.